Overview: Syphilis Serology TestIntroduction: The Syphilis Serology Test detects syphilis antibodies to diagnose syphilis, causing sores or rash. Aligned with 2023 CDC guidelines, it uses immunoassays for high specificity, supporting infection screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in serology for patients with suspected syphilis.
Other Names: Syphilis Antibody Assay, Treponemal Test.
FDA Status: Laboratory-developed test (LDT), meeting serology standards for diagnostic accuracy.
Historical Milestone: Syphilis serology began in the 1900s with Wassermann testing. Immunoassay methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Detects syphilis antibodies to diagnose syphilis, guides treatment, and evaluates patients with sores or rash.
Test Parameters: 1. Syphilis Antibodies
Pretest Condition: No fasting required. Collect serum. Report history of sores, rash, or sexual exposure.
Specimen: Serum (SST, 2-5 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document sores, rash, or history of sexually transmitted infections. Include current medications, especially antibiotics.
Consent: Written consent required, detailing the tests purpose, syphilis implications, and risks of sample collection.
Procedural Considerations: Uses enzyme immunoassay (EIA) or rapid plasma reagin (RPR) to detect syphilis antibodies. Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories, often for syphilis diagnosis.
Factors Affecting Result Accuracy: Sample hemolysis or improper storage can affect results. Early infection may yield false negatives.
Clinical Significance: Positive antibodies confirm syphilis, guiding antibiotic therapy. Negative results may require repeat testing or TPPA.
Specialist Consultation: Consult an infectious disease specialist for result interpretation and treatment planning.
Additional Supporting Tests: TPPA, FTA-ABS, or darkfield microscopy to confirm syphilis diagnosis.
Test Limitations: Non-specific for disease stage; clinical correlation is needed. Sample quality affects sensitivity.
References: CDC STI Guidelines, 2023; Sexually Transmitted Diseases, Workowski KA, 2022.
